The policy for protection of human subjects in research was adopted by more than a dozen federal entities
In 1991, the policy for protection of human subjects in research, promulgated in 1981 by the U.S. Food…
Regulations published to Accelerate the Review of Drugs for life-threatening diseases
In 1991, regulations published to Accelerate the Review of Drugs for life-threatening diseases. In Decemebr, 1992, the FDA…
Bristol-Myers’ cardiovascular medicines, PRAVACHOL (pravastin sodium) and MONOPRIL (fosinopril sodium) approved by the US Food and Drug Administration
In 1991, Bristol Myers Squibb’s cardiovascular medicines, PRAVACHOL (pravastin sodium) and MONOPRIL (fosinopril sodium) were approved by the…
The FDA approved PRP-OMP for routine administration to infants beginning at 2 months of age
On Dec. 13, 1990, the U.S. Food and Drug Administration (FDA) approved Haemophilus b Conjugate Vaccine (Meningococcal Protein…
The Safe Medical Devices Act was passed
On Nov. 28, 1990, the Safe Medical Devices Act was passed, requiring nursing homes, hospitals, and other facilities…
Nutrition Labeling and Education Act required all packaged foods to bear nutrition labeling
On Nov. 8, 1990, the Nutrition Labeling and Education Act was signed into law by President George H….
BOTOX(R) cosmetic (onabotulinumtoxinA) approved by the FDA
On Dec. 29, 1989, the U.S. Food and Drug Administration (FDA) approved Oculinum’s (onabotulinumtoxinA) for treatment of strabismus…
FDA issued a nationwide recall of all OTC dietary supplements containing 100 milligrams or more of L-Tryptophan
On Nov. 24, 1989, the U.S. Food and Drug Administration (FDA) issued a nationwide recall of all over-the-counter…
Recombinant hepatitis B vaccine (Engerix-B by SmithKline Beecham) was licensed
On Aug. 28, 1989, a second recombinant hepatitis B vaccine, Engerix-B (SmithKlineBeecham), was approved for use in the…
The FDA approved the hormone, called Epogen
On Jun. 1, 1989, the FDA approved Amgen’s Epogen/Procrit for the treatment of anemia associated with chronic renal…
Bristol-Myers’ PARAPLATIN (carboplatin) was approved for the treatment of recurrent ovarian cancer
On Mar. 3, 1989, the U.S. Food and Drug Administration (FDA) approved Bristol-Myers’ PARAPLATIN (carboplatin) for the treatment…
Carboplatin, a drug related to cisplatin, was approved by the Food and Drug Administration
In 1989, carboplatin, a drug related to cisplatin, was approved by the FDA for initial treatment of advanced…
Transgenic fast-growing salmon were created
In 1989, transgenic fast-growing salmon were created. In 2015, the U.S. Food and Drug Administration (FDA) approved a…
Cellpro was founded
In 1989, CellPro was founded in Bothell as a spin-off from the Fred Hutchinson Cancer Research Center. The…
Conjugated Haemophilus influenzae type b vaccine (HibTITER by Wyeth-Lederle) was licensed
On Dec. 21, 1988, the conjugated Haemophilus influenzae type b vaccine (HibTITER by Wyeth-Lederle) was licensed. Prior to…
The Prescription Drug Marketing Act banned the diversion of prescription drugs from legitimate commercial channels
On Apr. 22. 1988, the Prescription Drug Marketing Act of 1987 (PDMA) was signed into law by the…
Food and Drug Administration Act of 1988 officially established FDA as an agency of the Department of Health and Human Services
In 1988, Food and Drug Administration Act of 1988 officially established FDA as an agency of the Department…
The FDA enacted an accelerated regulatory process for products combating terminal diseases
In 1988, the FDA enacted accelerated regulatory process for products combating terminal diseases.
Drs. Fletcher Taylor and Charles Esmon at the OMRF established filed for a patent on discoveries fore blood clots
In 1988, Dr. Fletcher Taylor and Dr. Charles Esmon from the Oklahoma Medical Research Foundation (OMRF) filed for…
FDA approved Protein-conjugated Haemophilus influenzae type b vaccine (PRP-D, ProHibit by Connaught)
On Dec. 22, 1987, the protein-conjugated Haemophilus influenzae type b vaccine (PRP-D, ProHibit by Connaught) was licensed.
The Center for Biologics Evaluation and Research was created within the FDA
On Oct. 6, 1987, the Center for Drugs and Biologics within the U.S. Food and Drug Administration was…
Agriculture | Biotechnology | FDA | Life Science News | USDA
Advanced Genetic Sciences announced Frostban bacteria successfully protected strawberries from below-freezing temperatures
On Jun. 8, 1987, Advanced Genetic Sciences announced that its Frostban (Ice-minus) bacteria successfully protected strawberries from below-freezing…
Investigational drug regulations revised to expand access to experimental drugs for patients with no alternative therapies
In 1987, the U.S. Food and Drug Administration (FDA) announced revised regulations regarding Expanded Access (EA) to investigational…
Biotechnology | FDA | HIV | Life Science News | Therapeutics
The FDA approved first Western blot blood test more specific HIV diagnostic test and AZT as the first antiretroviral drug to be used as a treatment for AIDS
In 1987, the FDA approved first Western blot blood test more specific HIV diagnostic test and AZT as…
The antidepressant fluoxetine (Prozac), discovered by David T. Wong, was given FDA approval
In 1987, the antidepressant fluoxetine (Prozac), discovered by David T. Wong, was given U.S. Food and Drug Administration…
Genentech drug Activase (alteplase) was approved
In 1987, the U.S. Food and Drug Administration (FDA) approved Genentech’s drug tPA Activase (alteplase). Activase is a…
President Reagan signed the Anti-Drug Abuse Act of 1986, which outlawed the sale of steroids for non-medical purposes
On Oct. 27, 1986, President Ronald Reagan signed the the Anti-Drug Abuse Act of 1986. The Act changed…
Bill Schroeder, the second human recipient of the Jarvik 7 artificial heart, died after living 620 days
On Aug. 6, 1986, Bill Schroeder from Jasper, Indiana, the second human recipient of the Jarvik 7 artificial…
Interferon became the first anticancer drug produced through biotechnology
On Jun. 5, 1986, the U.S. Food and Drug Administration (FDA) approved Hoffmann La Roche’s Interferon initially for…
The first recombinant vaccine for humans, a vaccine for hepatitis B, was approved
In May 1986, the vaccine Recombivax HB, which protects against hepatitis B infection, was approved for marketing in…